Case Studies

An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...

Recent Blog Posts

Tony Coelho Discusses Patient Care with Former HHS Secretary
February 3, 2012 |

On Tuesday night, PIPC Chairman Tony Coelho joined former HHS Secretary Tommy Thompson at the University of Charleston in West Virginia for a speaker series titled "Who Decides Patient Treatments" to discuss the future of health care in the United States.

 | Read More
PCORI Releases their Draft Priorities
January 30, 2012 |

PCORI released a draft of their National Priorities for Research and Research Agenda for public comment. The PCORI Board, which is responsible for funding research, is asking for a 55 day public comment period to discuss and solicit feedback from patients, caregivers, professionals, and the general public on the research priorities.

In the draft, PCORI prioritized five broad research areas:

 | Read More
Differentiating Patients, Consumers, and Patient Advocacy Organizations
October 18, 2011 |

When conducting Comparative Effectiveness Research it is crucial to understand the differences between the players involved in the process. In his remarks at the  2nd Annual Forum on Achieving Patient centeredness , Marc Boutin, executive vice president and COO at the National Health Council, discussed the important differences between the three major players in the process: the patient, the consumer, and the patient advocacy organization. He stated that many times when the patient is discussed they are not defined.

 | Read More

For Reporters

For journalists and other media professionals

More Information

Stay Connected

About

Who we are:

The Partnership to Improve Patient Care (PIPC) is a diverse group of healthcare organization representing patients, physicians and other health care providers, researchers and innovators, and other groups that have come together to promote comparative effectiveness research that supports patient access and informed health care decision-making and fosters continued medical progress. PIPC is lead by a Steering Committee of twelve groups that represent the partnership's diverse members. The PIPC member list and steering committee reflect a wide range of support within the health care community.

What we do:

PIPC is dedicated to supporting comparative effectiveness research that strengthens physician and patient decision making, improves health care quality, and supports continued medical progress.

To make that happen, we aim to raise awareness:

  • About the value of well-designed comparative effectiveness research (CER).
  • About the need to ensure that proposals to expand the government's role in CER are centered on patient needs.
  • About the important role of continued medical innovation as part of the solution to cost and quality challenges in health.